Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-00-005372
Filing Date
2000-05-23
Accepted
2000-05-23 00:00:00
Documents
2
Period of Report
1999-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K 10-K/A 165055
2 CONSENT OF KPMG LLP EX-23 1020
  Complete submission text file 0000950123-00-005372.txt   167711
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 000-15190 | Film No.: 641831
SIC: 2835 In Vitro & In Vivo Diagnostic Substances